Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Cullinan Therapeutics (CGEM) Other Gross PP&E Adjustments (2020 - 2023)

Cullinan Therapeutics has reported Other Gross PP&E Adjustments over the past 4 years, most recently at -$2.9 million for Q3 2023.

  • Quarterly results put Other Gross PP&E Adjustments at -$2.9 million for Q3 2023, up 34.94% from a year ago — trailing twelve months through Sep 2023 was -$2.9 million (up 34.94% YoY), and the annual figure for FY2022 was -$2.8 million, down 1012.94%.
  • Other Gross PP&E Adjustments for Q3 2023 was -$2.9 million at Cullinan Therapeutics, up from -$3.5 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CGEM hit a ceiling of $309000.0 in Q4 2020 and a floor of -$4.5 million in Q3 2022.
  • Median Other Gross PP&E Adjustments over the past 4 years was -$2.8 million (2022), compared with a mean of -$2.1 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 1012.94% in 2022 and later soared 34.94% in 2023.
  • Cullinan Therapeutics' Other Gross PP&E Adjustments stood at $309000.0 in 2020, then changed by 0.0% to $309000.0 in 2021, then plummeted by 1012.94% to -$2.8 million in 2022, then dropped by 3.69% to -$2.9 million in 2023.
  • The last three reported values for Other Gross PP&E Adjustments were -$2.9 million (Q3 2023), -$3.5 million (Q2 2023), and -$3.8 million (Q1 2023) per Business Quant data.